UK government sets out a bold vision for the future of clinical research delivery
Patients, clinicians and researchers across the whole of the UK are set to benefit from the ambitious vision for the future of clinical research delivery.
March 24, England: Patients, clinicians and researchers across the whole of the UK are set to benefit from the ambitious vision for the future of clinical research delivery in the UK as the government sets out to create more efficient research delivery, more diverse and accessible research, and to embed research in the NHS.
Saving and improving lives: the future of UK clinical research delivery, published today and developed by the UK government and devolved administrations, sets out how will deliver faster, more efficient and more innovative research – from the streamlining of costing, contracting and approvals processes to the HRA’s rapid ethics review pilot, which aims to halve the time to provide a final opinion for research applications.
Using best practice, participating in research will become more accessible, increasing diversity and allowing more people across the whole of the UK to take part. Working with Centres of Excellence, such as the Centre for BME Health in Leicester, there will be more support for research in more diverse and under-served communities and innovative approaches like the University of Birmingham’s Dare2Think clinical trial, which has used remote eConsent and digital follow-up methods to recruit 3,000 patients across England with atrial fibrillation for their research.
The NHS will be encouraged to put the delivery of research at the heart of everything they do, making it an essential and rewarding part of effective patient care. This means building a culture across the NHS and all health and care settings that is positive about research, where all staff feel empowered and supported to take part in clinical research delivery as part of their job.
The COVID-19 pandemic has brought into focus the strength and importance of the UK’s research base. Rapid delivery of clinical trials, such as RECOVERY, have shown how the UK can set up trials in record time without any loss of rigour. These strengths in research delivery enabled the UK to identify the first proven treatment for COVID-19, dexamethasone, which has cut mortality rates by as much as one-third in COVID-19 patients needing ventilation and is estimated to have saved up to 27,000 lives in the UK and hundreds of thousands of lives around the world. Our research has also made a leading contribution to the international vaccine effort – shining a light on the pathway back to normality.
Important lessons have also been learned from the pandemic about where can be improved, such as empowering healthcare and research workers, who have worked to take care of us during the pandemic, to ensure our workforce is supported and resilient to future challenges. Have also seen the need to go even further in terms of innovative trial design and delivery.
The vision is built around 5 key themes:
Clinical research embedded in the NHS: to create a research-positive culture in which all health and care staff feel empowered to support and participate in clinical research as part of their job.
Patient-centred research: to make access and participation in research as easy as possible for everyone across the UK, including rural, diverse and under-served populations.
Streamlined, efficient and innovative research: so the UK is seen as the best place in the world to conduct fast, efficient and cutting-edge clinical research.
Research enabled by data and digital tools: to ensure the UK has the most advanced and data-enabled clinical research environment in the world, building on our unique data assets to improve health and care.
A sustainable and supported research workforce: which offers rewarding opportunities and exciting careers for all healthcare and research staff of all professional backgrounds – across both commercial and non-commercial research.
To deliver these aims, several priority areas have been identified, such as improving the speed and efficiency of setting up studies, building upon digital platforms to deliver clinical research, and making research more diverse and more relevant to the whole UK. This will break down traditional barriers and deliver a patient-centred and pro-innovation clinical research environment.
The launch of the UK-wide vision will be followed by implementation plans and strategies set out how the UK government and devolved administrations will begin to deliver the vision from 2021 to 2022.
The vision reflects the ambition of all 4 UK governments and has been developed through a broad cross-sector approach involving NHS, medical research charities, life sciences industry and academia. Continued collaboration across sectors and organisations will ensure the key action areas will be delivered.
Read more from the below TAGS
People also reading-
